<DOC>
	<DOC>NCT00989235</DOC>
	<brief_summary>The purpose of this exploratory sub-study was to evaluate from a clinical perspective the impact on disease activity of lowering the dose of abatacept from 10 mg/kg to 5 mg/kg in subjects who had achieved remission (Disease Activity Score 28 [DAS 28]-erythrocyte sedimentation rate [ESR] &lt; 2.6) at Day 701 of study IM101023.</brief_summary>
	<brief_title>Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>Subjects who have completed the main study, are willing to participate and have a DAS 28 ESR score of &lt; 2.6 on Day 701 of the main study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>NOS</keyword>
</DOC>